• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Page 4 > News & stories

Viewpoints

Page 4 > News & stories

Viewpoints

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2026

Results

No results found. Please try using different filter option(s).

Global Health Now
In the media
27 May 2026

The Long, Strange Journey of Mycetoma Research

Global Health Now
Scientific articles
14 May 2026

In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting

International Journal for Parasitology: Drugs and Drug Resistance
Statements
19 May 2026

DNDi interventions at the 79th World Health Assembly

Dr Sergio Sosa-Estani
Statements
15 May 2026

DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’

Scientific articles
13 May 2026

Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression

PLOS Pathogens
Statements
13 May 2026

DNDi’s briefing note for 79th World Health Assembly

Close up of legs with sandals on a dry soil
Press releases
12 May 2026

DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai

Thai Rath logo
In the media
29 Apr 2026

Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure

Thai Rath
Scientific articles
14 May 2026

Mycetoma as a major cause of limb amputation in Northeastern Ethiopia: A facility-based retrospective study

PLOS Neglected Tropical Diseases
Nature Africa logo
In the media
6 May 2026

Fourteen days to recovery from kala-azar

Nature Africa
Scientific articles
30 Apr 2026

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination

npj Antimicrobials and Resistance
Thai Rath logo
In the media
29 Apr 2026

ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด

Thai Rath
Press releases
27 Apr 2026

Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients

Alma Preta logo
In the media
25 Apr 2026

‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África

Alma Preta
Times of India logo
In the media
24 Apr 2026

Dengue treatments in 2-3 years, but cases set to rise with climate change

Times of India
The New Indian Express logo
In the media
23 Apr 2026

India eyes dengue treatment rollout within five years as vaccine pipeline advances

The New Indian Express
loading
Loading...
Viewpoints
6 Aug 2021

Will science deliver needed therapeutics for COVID-19—and how can equitable access be ensured?

British Medical Journal (BMJ)
Patient at doctors appointment
Viewpoints
26 Jul 2021

L’hépatite C, cette épidémie dont les morts n’intéressent personne

Libération
Viewpoints
17 Jun 2021

The story of a ‘political drug’ against hepatitis C

Geneva Solutions
Man with his wife sitting on a bench
Viewpoints
14 Jun 2021

Public-private partnerships can accelerate the end of hepatitis C

Researchers working in rural village with microscope
Viewpoints
16 Apr 2021

Shortfall in research funding for the most neglected diseases

Viewpoints
8 Mar 2021

Gender-responsive R&D, women in science, and access to COVID-19 health tools: DNDi Board Chair Marie-Paule Kieny on International Women’s Day

Viewpoints
7 Feb 2021

Esquecidos pela Medicina

O Globo
Viewpoints
30 Jan 2021

Innovation and collaboration can help to eliminate neglected tropical diseases (NTD)

The Economic Times
Viewpoints
30 Jan 2021

¿Ciencia a dos velocidades? Un llamamiento por las enfermedades tropicales desatendidas

El Pais
Viewpoints
29 Jan 2021

L’extraordinaire mobilisation scientifique autour du Covid-19 doit aussi s’appliquer aux « maladies négligées »

La Croix
Viewpoints
29 Jan 2021

The UK must take the lead in wiping out the world’s forgotten diseases

The Telegraph
Viewpoints
29 Jan 2021

Innovation – and research – are key to killing off neglected tropical diseases in Africa

The Conversation
Laboratory staff working
Viewpoints
28 Jan 2021

WHO 2030 NTDs Roadmap: how science and partnerships can support the fight to end neglected diseases

Viewpoints
18 Dec 2020

Gender and R&D: DNDi effectively mobilized

Viewpoints
24 Nov 2020

Now is the time to innovate for more than 1 billion people with neglected tropical diseases

STAT
Viewpoints
11 Nov 2020

Strong leadership fought COVID-19 in Africa: the next step is to harness research

The Conversation
1 2 … 6 ›

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.  

Linkedin Instagram X-twitter Facebook Youtube
EM PORTUGUÊS
EN ESPAÑOL
Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license